In this issue:
US radiation therapy trends after radical prostatectomy
Olaparib for mCRPC
Observation vs SABR for oligometastatic prostate cancer
NeuroSAFE: nerve-sparing surgery in prostate cancer patients
Utility of the Genomic Prostate Score
Prognostic utility of a subclassification for high-risk prostate cancer
Abiraterone exposure-response in real-world patients with mCRPC
Prostate cancer in kidney transplant recipients
Primary treatments for high-risk localised/locally advanced prostate cancer
Please login below to download this issue (PDF)